Benitec Biopharma (BNTC) Interest Expenses (2019 - 2025)
Benitec Biopharma (BNTC) posted Interest Expenses of $14.8 million for Q4 2025, down 99.91% sequentially from $17.4 billion in Q3 2025, and down 99.86% YoY from $10.4 billion in Q4 2024.
Benitec Biopharma (BNTC) Interest Expenses (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Interest Expenses for 7 years, with the latest figure at $14.8 million in Q4 2025.
- Quarterly Interest Expenses fell 99.86% year-over-year to $14.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.8 million (down 99.86% YoY) and the FY2025 annual result came in at $7.7 billion, up 229.87% from the prior year.
- Interest Expenses fell to $14.8 million in Q4 2025 per BNTC's latest filing, from $17.4 billion in the prior quarter.
- Over five years, Interest Expenses peaked at $17.4 billion in Q3 2025 and troughed at $8000.0 in Q1 2021.
- A 5-year average of $2.4 billion and a median of $1.2 million in 2022 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2024 and 2025: Interest Expenses jumped 1420480.41% in 2024, then tumbled 99.98% in 2025.
- Over 5 years, Interest Expenses stood at $152000.0 in 2021, then soared by 378.29% to $727000.0 in 2022, then jumped by 1451.99% to $11.3 million in 2023, then surged by 92138.5% to $10.4 billion in 2024, then plunged by 99.86% to $14.8 million in 2025.
- According to Business Quant data, Interest Expenses over the past three periods registered $14.8 million, $17.4 billion, and $356000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | 14.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.82 Mn |
| Dec 31, 2025 | 14.82 Mn |
| Sep 30, 2025 | 17.37 Bn |
| Sep 30, 2025 | 17.37 Bn |
| Jun 30, 2025 | 356,000.00 |
| Jun 30, 2025 | 356,000.00 |
| Mar 31, 2025 | 12.16 Bn |
| Mar 31, 2025 | 12.16 Bn |
| Dec 31, 2024 | 10.41 Bn |
| Dec 31, 2024 | 10.41 Bn |
| Sep 30, 2024 | 4.86 Bn |
| Sep 30, 2024 | 4.86 Bn |
| Jun 30, 2024 | 2.34 Bn |
| Jun 30, 2024 | 2.34 Bn |
| Mar 31, 2024 | 353.29 Mn |
| Mar 31, 2024 | 353.29 Mn |
| Dec 31, 2023 | 11.28 Mn |
| Dec 31, 2023 | 11.28 Mn |
| Sep 30, 2023 | 342,000.00 |
| Sep 30, 2023 | 342,000.00 |